Dietary unsaponifiable fraction from extra virgin olive oil supplementation attenuates acute ulcerative colitis in mice

European Journal of Pharmaceutical Sciences

Volumn 48, Issue 3, 2013, Pages 572-581

  Sanchez Fidalgo S ^a   Cardeno A ^a   Sanchez Hidalgo M ^a   Aparicio Soto, M ^a   Villegas, I ^a   Rosillo, M A ^a   De La Lastra, C Alarcón ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

COX 2; Extra virgin olive oil; IjBa; INOS; MAPK; Unsaponifiable fraction

Indexed keywords

CYCLOOXYGENASE 2; EXTRA VIRGIN OLIVE OIL; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIVE OIL; SUNFLOWER OIL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; NONSTEROID ANTIINFLAMMATORY AGENT; NOS2 PROTEIN, MOUSE; PLANT EXTRACT; PTGS2 PROTEIN, MOUSE; VEGETABLE OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ACTIVITY SCORE; FEEDING; FEMALE; HISTOPATHOLOGY; MICROSCOPIC ANATOMY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; UPREGULATION; WEANING; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMISTRY; COLITIS, ULCERATIVE; COLON; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HYDROLYSIS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; RANDOMIZATION; STANDARDS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMOKINE CCL2; COLITIS, ULCERATIVE; COLON; CYCLOOXYGENASE 2; DIETARY SUPPLEMENTS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; HYDROLYSIS; INTESTINAL MUCOSA; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLANT EXTRACTS; PLANT OILS; RANDOM ALLOCATION; TUMOR NECROSIS FACTOR-ALPHA; WEANING;

EID: 84875441699     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.12.004     Document Type: Article

References (42)

1. Abia, R., Pacheco, Y.M., Perona, J.S., Montero, E., Muriana, F.J., Ruiz-Gutiérrez, V., 2001. The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men. J. Nutr. 131, 59-65.
2. Awad, A.B., Downie, A., Fink, C.S., Kim, U., 2000. Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice. Anticancer Res. 20, 821-824.
3. Bento, A.F., Leite, D.F., Claudino, R.F., Hara, D.B., Leal, P.C., Calixto, J.B., 2008. The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J. Leukoc. Biol. 84, 1213-1221.
4. Bermudez, B., Lopez, S., Ortega, A., Varela, L.M., Pacheco, Y.M., Abia, R., Muriana, F.J., 2011. Oleic acid in olive oil: From a metabolic framework toward a clinical perspective. Curr. Pharm. Des. 17, 831-843.
5. Bouic, P.J., 2002. Sterols and sterolins: New drugs for the immune system? Drug Discov. Today 7, 775-778.
6. Braus, N.A., Elliott, D.E., 2009. Advances in the pathogenesis and treatment of IBD. Clin. Immunol. 132, 1-9.
7. Bulló, M., Lamuela-Raventós, R., Salas-Salvadó, J., 2011. Mediterranean diet and oxidation: Nuts and olive oil as important sources of fat and antioxidants. Curr. Top. Med. Chem. 11, 1797-1810.
8. Commission Regulation (EEC) No 2568/91 of 11 July 1991 on the characteristics of olive oil and olive-residue oil and the relevant methods of analysis. Off J. Eur. Communities, p. 248.
9. Coskun, M., Olsen, J., Seidelin, J.B., Nielsen, O.H., 2011. MAP kinases in inflammatory bowel disease. Clin. Chim. Acta 412, 513-520.
10. de la Lastra, C.A., 2011. An up-date of olive oil and bioactive constituents in health: Molecular mechanisms and clinical implications. Curr. Pharm. Des. 17, 752-753.
11. Dieleman, L.A., Palmen, M.J., Akol, H., Bloemena, E., Pena, A.S., Meuwissen, S.G., Van Rees, E.P., 1998. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 114, 385-391.
12. Docena, G., Rovedatti, L., Kruidenier, L., Fanning, A., Leakey, N.A., Knowles, C.H., Lee, K., Shanahan, F., Nally, K., McLean, P.G., Di Sabatino, A., MacDonald, T.T., 2010. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. Clin. Exp. Immunol. 62, 108-115.
13. Dubuquoy, L., Rousseaux, C., Thuru, X., Peyrin-Biroulet, L., Romano, O., Chavatte, P., Chamaillard, M., Desreumaux, P., 2006. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 55, 1341-1349.
14. Ghanbari, R., Anwar, F., Alkharfy, K.M., Gilani, A., Saari, N., 2012. Valuable nutrients and functional bioactives in different parts of olive (Olea europaea L.)-a review. Int. J. Mol. Sci. 13, 3291-3340.
15. Hegazi, R.A., Saad, R.S., Mady, H., Matarese, L.E., O'Keefe, S., Kandil, H.M., 2006. Dietary fatty acids modulate chronic colitis, colitis associated colon neoplasia and COX-2 expression in IL-10 knockout mice. Nutrition 22, 275-282.
16. Itzkowitz, S.H., 2006. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol. Clin. North Am. 35, pp. 553-371.
17. Kaliora, A.C., Stathopoulou, M.G., Triantafillidis, J.K., Dedoussis, G.V., Andrikopoulos, N.K., 2007. Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic. World J. Gastroenterol. 13, 6031-6036.
18. Kaminska, B., 2005. MAPK signalling pathways as molecular targets for antiinflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 1754, 253-262.
19. Kim, J.M., Jung, H.Y., Lee, J.Y., Youn, J., Lee, C.H., Kim, K.H., 2005. Mitogen-activated protein kinase and activator protein-1 dependent signals are essential for bacteroides fragilis enterotoxininduced enteritis. Eur. J. Immunol. 35, 2648-2657.
20. Kolios, G., Valatas, V., Ward, S.G., 2004. Nitric oxide in inflammatory bowel disease: A universal messenger in an unsolved puzzle. Immunology 113, 427-437.
21. Lampi, A.M., 1997. Tocopherols and tocotrienols in vegetable oils and fats by HPLC. The AOCS Lipid Library Ce, pp. 8-89.
22. Lee, I.A., Kim, E.J., Kim, D.H., 2012. Inhibitory effect of b-sitosterol on TNBS-induced colitis in mice. Planta Med. 78, 896-898.
23. McGuckin, M.A., Eri, R., Simms, L.A., Florin, T.H., Radford-Smith, G., 2009. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm. Bowel Dis. 15, 100-113.
24. Melgar, S., Karlsson, A., Michaëlsson, E., 2005. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice. Correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1328-G1338.
25. Molodecky, N.A., Soon, I.S., Rabi, D.M., Ghali, W.A., Ferris, M., Chernoff, G., Benchimol, E.I., Panaccione, R., Ghosh, S., Barkema, H.W., Kaplan, G.G., 2012. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46-54.
26. Nieto, N., Torres, M.I., Ríos, A., Gil, A., 2002. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J. Nutr. 132, 11-19.
27. Orozco, M.I., Priego-Capote, F., Luque de Castro, M.D., 2011. Influence of deep frying on the unsaponifiable fraction of vegetable edible oils enriched with natural antioxidants. J. Agric. Food Chem. 59, 7194-7202.
28. Owen, R.W., Mier, W., Giacosa, A., Hull, W.E., Spielgelhalder, B., Bartsch, H., 2000. Phenolic compounds and squalene in olive oils: The concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignans and squalene. Food Chem. Toxicol. 38, 647-659.
29. Perona, J.S., Avella, M., Botham, K.M., Ruiz-Gutierrez, V., 2006. Uptake of triacylglycerol-rich lipoproteins of differing triacylglycerol molecular species and unsaponifiable content by liver cells. Br. J. Nutr. 95, 889-897.
30. Rosillo, M.A., Sanchez-Hidalgo, M., Cárdeno, A., de la Lastra, C.A., 2011. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem. Pharmacol. 82, 737-745.
31. Rosillo, M.A., Sánchez-Hidalgo, M., Cárdeno, A., Aparicio-Soto, M., Sánchez-Fidalgo, S., Villegas, I., de la Lastra, C.A., 2012. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol. Res. 66, 235-242.
32. Sánchez-Fidalgo, S., Villegas, I., Cárdeno, A., Talero, E., Sánchez-Hidalgo, M., Motilva, V., de la Lastra, C. Alarcón, 2010a. Extra virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice. Clin. Nutr. 29, 663-673.
33. Sánchez-Fidalgo, S., Cárdeno, A., Villegas, I., Talero, E., de la Lastra, C.A., 2010b. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur. J. Pharmacol. 633, 78-84.
34. Sánchez-Fidalgo, S., Sánchez de Ibargüen, L., Cárdeno, A., de la Lastra, C. Alarcón, 2012. Influence of extra virgin olive oil diet enriched with hydroxytyrosol in a chronic DSS colitis model. Eur. J. Nutr. 51, 497-506.
35. Sato, K., Kanazawa, A., Ota, N., Nakamura, T., Fujimoto, K., 1998. Dietary supplementation of catechins and alpha-tocopherol accelerates the healing of trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. J. Nutr. Sci. Vitaminol (Tokyo) 44, 769-778.
36. Schneider, H., Braun, A., Füllekrug, J., Stremmel, W., Ehehalt, R., 2010. Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation. Int. J. Mol. Sci. 11, 4149-4164.
37. Sofi, F., Abbate, R., Gensini, G.F., Casini, A., 2010. Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis. Am. J. Clin. Nutr. 92, 1189-1196.
38. Stremmel, W., Hanemann, A., Ehehalt, R., Karner, M., Braun, A., 2010. Phosphatidylcholine (lecithin) and the mucus layer: Evidence of therapeutic efficacy in ulcerative colitis? Dig. Dis. 28, 490-496.
39. van Rensburg, S.J., Daniels, W.M., van Zyl, J.M., Taljaard, J.J., 2000. A comparative study of the effects of cholesterol, beta-sitosterol, beta-sitosterol glucoside, dehydroepiandrosterone sulphate and melatonin on in vitro lipid peroxidation. Metab. Brain Dis. 15, 257-265.
40. Wei, J., Feng, J., 2010. Signaling pathways associated with inflammatory bowel disease. Recent Pat. Inflammation Allergy Drug Discovery 4, 105-117.
41. Wullaert, A., Bonnet, M.C., Pasparakis, M., 2011. NFjB in the regulation of epithelial homeostasis and inflammation. Cell Res. 21, 146-158.
42. Zhao, C.C., Shao, J.H., Li, X., Xu, J., Zhang, P., 2005. Antimicrobial constituents from fruits of Ailanthus altissima SWINGLE. Arch. Pharm. Res. 28, 1147-1151.